{
    "clinical_study": {
        "@rank": "133006", 
        "acronym": "HMM/P", 
        "arm_group": [
            {
                "arm_group_label": "nothing at home level", 
                "arm_group_type": "No Intervention", 
                "description": "No intervention at community level. The study drugs (arthemeter/Lumefantrine and Cotrimoxazole) available at the health facility drug stores level and prescribed exclusively to sick children attending to the health facility for care seeking. No Community Heath Worker /Key Opinion leader (CHWs/KOLs) selected in those clusters"
            }, 
            {
                "arm_group_label": "Home management of malaria", 
                "arm_group_type": "Experimental", 
                "description": "At the community level, the Community health workers/ keay opinion leader (HWs/KOLs) trained and equipped  to provide the antimalarial drug (arthemeter/Lumefantrine ) to any child with fever (\"hot body\") without any other signs of complications like impaired consciousness, convulsions, etc"
            }, 
            {
                "arm_group_label": "Home management of malaria and pneumonia", 
                "arm_group_type": "Experimental", 
                "description": "At the community level, the Community health workers/ key opinion leader (HWs/KOLs) trained and equipped to provide the antimalarial drug (arthemeter/Lumefantrine ) or antibiotic (Cotrimoxazole) to any child with fever (\"hot body\") without any other signs of complications like impaired consciousness, convulsions, etc. The treatment decision making for the CHWs/KOLs based on the algorithm"
            }
        ], 
        "brief_summary": {
            "textblock": "A well-implemented community-based program of early and appropriate treatment of\n      fevers/malaria episodes and pneumonia,will improve child survival as measured by a reduction\n      of the less than five mortality rate."
        }, 
        "brief_title": "Home Management of Malaria and Pneumonia", 
        "completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Malaria", 
            "Pneumonia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Malaria", 
                "Pneumonia"
            ]
        }, 
        "detailed_description": {
            "textblock": "An integrated approach of home and community management of malaria and pneumonia may\n      increase the proportion of children receiving prompt treatment; improve child survival as\n      measured by a reduction of the under five mortality rate. To test this hypothesis, a cluster\n      randomised controlled trial will be performed, involving children less than 5 years of age,\n      in Burkina Faso using a community-based supplying community health workers (CHWs), a core\n      group of mothers (KOLs) with Coartem and cotrimoxazole specially packed in age-specific\n      blisters containing a full course of treatment. The study will be carried out in 111\n      clusters of a rural district in Burkina Faso where malaria and pneumonia are two major\n      mortality causes in under five mortality."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  living in one of the study cluster (villages)\n\n          -  no story of allergy to any of the study drugs\n\n          -  history of fever or body temperature >= 38.5\u00b0C\n\n        Exclusion Criteria:\n\n          -  signs of severity/complications like impaired consciousness, convulsions, fast\n             breathing etc"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "59 Months", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": {
            "#text": "11500", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02151578", 
            "org_study_id": "HMMP001", 
            "secondary_id": "A70210"
        }, 
        "intervention": {
            "arm_group_label": [
                "Home management of malaria", 
                "Home management of malaria and pneumonia"
            ], 
            "intervention_name": "home/community case management", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Impact of home management of malaria and pneumonia on child mortality", 
            "home management of malaria and pneumonia"
        ], 
        "lastchanged_date": "May 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ouagadougou", 
                    "country": "Burkina Faso", 
                    "state": "Kadiogo"
                }, 
                "name": "Groupe de Recherche Action en Sante (GRAS sarl)"
            }
        }, 
        "location_countries": {
            "country": "Burkina Faso"
        }, 
        "number_of_arms": "3", 
        "official_title": "Home and Community Management of Fevers/Malaria and Pneumonia in Children Under-five: a Cluster Randomised Controlled Trial of an Integrated Approach in a Rural District of Burkina Faso", 
        "other_outcome": {
            "measure": "Adverse events at community level consecutive to the administration of the cotrimoxazole and arthemeter/lumefantrine", 
            "safety_issue": "Yes", 
            "time_frame": "7 days after the administration of the drug"
        }, 
        "overall_official": {
            "affiliation": "Groupe de Recherche Action en sant\u00e9 (GRAS), 06 BP 10248 Ouagadougou 06, Burkina Faso", 
            "last_name": "Sodiomon Bienvenu SIRIMA, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Burkina Faso: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "annual crude mortality rate in children aged 0 to 6 months in the different study arms", 
            "measure": "Number of death in children aged 6 to 59 months", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02151578"
        }, 
        "responsible_party": {
            "investigator_affiliation": "World Health Organization", 
            "investigator_full_name": "Sodiomon B. Sirima", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "- specific mortality preceded by acute febrile illness of children aged 6 to 59 months -  severe malaria cases at community level", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "World Health Organization", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "World Health Organization", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}